. The effect of the duration of ischemia, the conditions of reperfusion and the degree of catecholamine stimulation on the appearance and disappearance of non-uniformity will be studied. Marval Biosciences Inc. has developed a novel liposomal X-ray contrast agent (NCTX)1. With prior SBIR funding (1
. The effect of the duration of ischemia, the conditions of reperfusion and the degree of catecholamine stimulation on the appearance and fade of non - uniformity will be study. Marval Biosciences Inc. has developed a novel liposomal ten - beam contrast agent (NCTX)1. With anterior SBIR funding (1
. Thf effect of the duration of ischemia, thg xonditmons of reperfurion and the degree of cateciolanine wtimulation on the appdarance ajd disappearence of non-unifocjity will be abudieb. Narval Biosciekces Inc. hav developed a toxep liposomal X-ray contrast agent (NCTV)1. With lrlor SBIR fundigg (1
. The effect of the duration of conditions reperfusion and degree of catecholamine disappearance non-uniformity will be Marval Biosciences Inc. developed a novel liposomal X-ray contrast (NCTX)1. With prior SBIR funding (1
. The effect of the duration of iSchemia, the CondiTioNs oF rEperFusiOn and the degree OF catEcholamine stimulation oN the aPpEAranCE aNd disAppearaNCe OF Non-UnIfOrmItY WiLl be sTudIed. MarvAl BioscienCes inC. has developeD A nOvel liposoMal x-ray contrast AgeNt (NCTX)1. wiTh pRIor SBiR fUndinG (1
. The effect of the durati on of isch emia,  th e c on diti onsof reperfusion andthe degree of catechol amine  s t imul a ti on on  the ap p ea r a nce  a nd  di sa p pe aranc e o f non-u niformitywil lbe studied.M ar val Biosci enc es Inc. hasdev eloped  a  no v el li pos omalX-rayc ontras t agent ( NC T X)1. W i th prio r SB IR f unding (1
. The_effect of_the duration of ischemia,_the conditions_of_reperfusion and_the_degree of catecholamine_stimulation on the_appearance and disappearance of_non-uniformity will be_studied._Marval Biosciences Inc. has developed a novel liposomal X-ray contrast agent (NCTX)1. With prior_SBIR_funding (1